Sage Therapeutics (FRA:SG7) YoY Rev. per Sh. Growth : 316.67% (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sage Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Sage Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 316.67%.

Sage Therapeutics's Revenue per Share for the three months ended in Sep. 2024 was €0.18.

Sage Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Sage Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sage Therapeutics YoY Rev. per Sh. Growth Chart

Sage Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY Rev. per Sh. Growth

Get a 7-Day Free Trial

-92.91

14,063.93

-99.45

28.42

986.07

Sage Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
YoY Rev. per Sh. Growth	Get a 7-Day Free Trial															40.00	2,548.89	132.69	250.00	316.67

Sage Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Sage Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY Rev. per Sh. Growth (A: Dec. 2023 )
=	(Revenue per Share (A: Dec. 2023 )	-	Revenue per Share (A: Dec. 2022 ))	/	\| Revenue per Share (A: Dec. 2022 ) \|
=	(1.325	-	0.122)	/	\| 0.122 \|
=	986.07 %

Sage Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

	YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=	(Revenue per Share (Q: Sep. 2024 )	-	Revenue per Share (Q: Sep. 2023 ))	/	\| Revenue per Share (Q: Sep. 2023 )) \|
=	(0.175	-	0.042)	/	\| 0.042 \|
=	316.67 %

Sage Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Sage Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sage Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sage Therapeutics Inc (FRA:SG7) » Definitions » YoY Rev. per Sh. Growth

Comparable Companies

Traded in Other Exchanges

SAGE:USA SG7:Germany

Address

215 First Street, Cambridge, MA, USA, 02142

Website

https://www.sagerx.com

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Sage Therapeutics Headlines

No Headlines